[1. Ochieng J, Chaudhuri G: Cystatin superfamily. J Health care poor underserved 2010, 21:51-70.10.1353/hpu.0.0257]Search in Google Scholar
[2. Turk V, Stoka V, Turk D: Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 2008, 13:5406-5420.10.2741/3089]Search in Google Scholar
[3. Turk B, Turk D, Salvesen GS: Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des 2002, 8(18):1623-37.10.2174/1381612023394124]Search in Google Scholar
[4. Ni J, Abrahamson M, Zhang M, Fernandez MA, Grubb A, Su J, Yu GL, Li Y, Parmelee D, Xing L, Coleman TA, Gentz S, Thotakura R, Nguyen N, Hesselberg M, Gentz R: Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 1997, 272(16):10853-10858.10.1074/jbc.272.16.10853]Search in Google Scholar
[5. Sánchez A, Vázquez A: Bioactive peptides: A review. Food Qual Saf 2017, 1:29–46.10.1093/fqs/fyx006]Search in Google Scholar
[6. Bouglé D, Bouhallab S: Dietary bioactive peptides: Human studies. Crit Rev Food Sci Nutr 2017, 57(2):335-343.10.1080/10408398.2013.873766]Search in Google Scholar
[7. Sim JS, Nakai S, Guenter W: Egg Nutrition and Biotechnology. Wallingford, UK: CAB Int; 2000, 205-217.10.1079/9780851993300.0000]Search in Google Scholar
[8. Neurath H: Evolution of proteolytic enzymes. Sci 1984, 224(4647):350-357.10.1126/science.6369538]Search in Google Scholar
[9. Tavano OL: Protein hydrolysis using proteases: An important tool for food biotechnology. J Mol Catal B Enzym 2013, 90:1-11.10.1016/j.molcatb.2013.01.011]Search in Google Scholar
[10. Cygler M, Morb JS: Proregion structure of members of the papain superfamily. modeof inhibition of enzymatic activity. Biochem 1997, 79:645-65210.1016/S0300-9084(97)83497-9]Search in Google Scholar
[11. Matsumoto I, Emori Y, Abe K, Arai S. Characterization of a gene family encoding cysteine proteinases of Sitophilus zeamais (maize weevil), and analysis of the protein distribution in various tissues including alimentary tract and germ cells. J Biochem 1997, 121(3):464-76.10.1093/oxfordjournals.jbchem.a0216119133615]Search in Google Scholar
[12. Turk V, Bode W: The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991, 285(2):213-219.10.1016/0014-5793(91)80804-C]Search in Google Scholar
[13. Jouanin, L, Bonadé-Bottino M, Girard C, Morrot G, Giband M: Transgenic plants for insect resistance. Plant Sci 1998, 131:1-11.10.1016/S0168-9452(97)00239-2]Search in Google Scholar
[14. Domoney C, Welhan I, Sidebotton C: Purification and characterization of Pisum seed trypsin Inhibitors. J Exp Bot 1993, 44(261):701-709.10.1093/jxb/44.4.701]Search in Google Scholar
[15. Zavasnik-Bergant T: Cystatin protease inhibitors and immune functions. Front Biosci 2008, 13:4625-4637.10.2741/3028]Search in Google Scholar
[16. Colella R, Sakaguchi, Y, Nagase H, Bird JWC: Chicken egg white cystatin. J Biol Chem 1989, 264:17164-17117.10.1016/S0021-9258(18)71473-7]Search in Google Scholar
[17. Barrett AJ: The Cystatins; a new class of peptidase inhibitors. Trend Biochem Sci 1987, 12:193-196.10.1016/0968-0004(87)90092-2]Search in Google Scholar
[18. Arai S, Matsumoto I, Emori Y, Abe K: Plant seed cystatins and their target enzymes of endogenous and exogenous origin. J Agric Food Chem 2002, 50(22): 6612–6617.10.1021/jf020193512381160]Search in Google Scholar
[19. Benchabane M, Schlüter U, Vorster J, Goulet MC, Michaud D: Plant cystatins. Biochimie 2010, 92(11):1657–1666.10.1016/j.biochi.2010.06.00620558232]Search in Google Scholar
[20. Sato, N, Ishidoh K, Uchiyama Y, Kominami E: Molecular cloning and sequencing of cDNA for rat cystatin b. Nucleic Acids Res 1990, 18(22):669810.1093/nar/18.22.66983326432251135]Search in Google Scholar
[21. Magister S, Kos, J: Cystatins in immune system. J Cancer 2013, 4(1):45–56.10.7150/jca.5044356424623386904]Search in Google Scholar
[22. Cornwall GA, Hsia N: A new subgroup of the family 2 cystatins. Mol Cell Endocrinol 2003, 200(1-2):1–8.10.1016/S0303-7207(02)00408-2]Search in Google Scholar
[23. Amin F, Khan MS, Bano B: Mammalian cystatin and protagonists in brain diseases. J Biomol Struct Dyn 2020, 38(7):2171–2196.10.1080/07391102.2019.1620636]Search in Google Scholar
[24. Zhou L, Li-Ling J, Huang H, Ma F, Li Q: Phylogenetic analysis of vertebrate kininogen genes. Genomics 2008, 91(2):129–141.10.1016/j.ygeno.2007.10.007]Search in Google Scholar
[25. Lee C, Bongcam-Rudloff E, Sollner C, Jahnen-Dechent W, Claesson-Welsh L: Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein. Front Biosci-Landmrk 2009, 14:2911–2922.10.2741/3422]Search in Google Scholar
[26. Saitoh F, Isemura S, Sanada K, Ohnishi K: Cystatins of family II are harboring two domains which retain inhibitory activities against the proteinase. Biol Biophys Res Commun 1991, 175:1070-1075.10.1016/0006-291X(91)91674-2]Search in Google Scholar
[27. Brzin J, Popovic T, Drobnic-Kosorok M, Kotnik M. Turk V: Inhibitors of cysteine proteinases from potato. Biol Chem Hoppe Seyler 1988, 369:233-238.]Search in Google Scholar
[28. Barrett AJ, Fritz H, Grubb A, Isemura S, Javirnen M, Katunuma N, Machleidt W, Muller-Esterl W, Sasaki M, Turk V: Nomenclature and classification of the proteins homologous with the cysteine proteinase inhibitor chicken cystatin. Biochem J 1986, 236:31210.1042/bj236031211468243491603]Search in Google Scholar
[29. Turk B, Turk V, Turk D: Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 1997, 378:141-150.]Search in Google Scholar
[30. Martinez M, Santamaria ME, Diaz-Mendoza M, Arnaiz A, Carrillo L, Ortego F, Diaz I: Phytocystatins: Defense proteins against Phytophagous insects and acari. Int. J Mol Sci 2016, 17(10):1747.10.3390/ijms17101747508577427775606]Search in Google Scholar
[31. Pernas, M.; Sanchez-Monge, R.; Gomez, L. and Salcedo, G: A chestnut seed cystatin differentially effective against cysteine proteinases from closely related pests. Plant Mol Biol 1998, 38(6):1235-1242.10.1023/A:1006154829118]Search in Google Scholar
[32. Walsh, T. A. and Strickland, J. A: Proteolysis of the 85-kilodalton crystalline cysteine proteinase inhibitor from potato release functional cystatin domains. Plant Physiol 1993, 103(4):1227-1234.10.1104/pp.103.4.12271591108290629]Search in Google Scholar
[33. Bolter CJ: Methyl jasmonate induces papain inhibitor(s) in tomato leaves. Plant Physiol 1993, 103:1347-135.10.1104/pp.103.4.134715912512232028]Search in Google Scholar
[34. Abe M, Abe K, Iwabuchi K, Domoto C, Arai S: Corn cystatin I expressed in Escherichia coli: investigation of its inhibitory profile and occurrence in corn kernels. J Biochem 1994, 116 (3):488-492.10.1093/oxfordjournals.jbchem.a124551]Search in Google Scholar
[35. Zhao Y, Botella MA, Subramanian L, Niu X, Nielson SS, Bressan RA, Hasegawa, PM: Two wound inducible soybean cysteine proteinase inhibitors have greater insect digestive proteinase inhibitory activities then a constitutive homolog. Plant Physiol 1996, 111:1299-1306.10.1104/pp.111.4.1299]Search in Google Scholar
[36. Amin F, Khan MS, Bano B:. Mammalian cystatin and protagonists in brain diseases. J Biomol Struct Dyn 2020, 38(7):2171–2196.10.1080/07391102.2019.1620636]Search in Google Scholar
[37. Vray B, Hartmann S, Hoebeke J: Immunomodulatory properties of cystatins. Cellular and molecular life sciences: CMLS 2002, 59(9):1503–151210.1007/s00018-002-8525-4]Search in Google Scholar
[38. Lindahi P, Nycander M, Ylienjaryi K, Pol E, Bjork I: Characterization by rapid-kinetic and equilibrium methods of the reaction between N-terminally truncated forms of chicken cystatin and the cysteine proteinases papain and actinidin. Biochem J 1992, 286:165-17110.1042/bj2860165]Search in Google Scholar
[39. Henskens YMC, Veerman ECJ, Amerongen AVN: Cystatins in health and disease. Biol Chem 1996, 377:71-86.]Search in Google Scholar
[40. Cimerman N, Prebanda MT, Turk B, Popovic T, Dolenc I, Turk V: Interaction of cystatin C variants with papain and human cathepsins B, H, and L. J. Enz Inhibit 1999, 14:167–174.10.3109/14756369909036552]Search in Google Scholar
[41. Turk D, Guncar G, Podobnik M, Turk B: Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem 1998, 379:137-147.10.1515/bchm.1998.379.2.137]Search in Google Scholar
[42. Mason RW, Sol-Church K, Abrahamson M: Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases. Biochem J 1998, 330:833-838.10.1042/bj3300833]Search in Google Scholar
[43. Nycander M, Estrada S, Mort JS, Abrahamson M, Bjork I: Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of proteinases occluding loop. FEBS. Lett 1998, 422:61-64.10.1016/S0014-5793(97)01604-9]Search in Google Scholar
[44. Sanders A, Jeremy Craven C, Higgins LD, Giannini S, Conroy MJ, Hounslow AM, Waltho JP, Staniforth RA: Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis. J Mol Biol 2004, 336(1):165-7810.1016/j.jmb.2003.12.01114741212]Search in Google Scholar
[45. Olsson SL, Ek B, Wilm M, Broberg S, Pask L: Bjork I. Molecular cloning and N-terminal analysis of bovine cystatin C. Identification of full-length N-terminal region. Biochem Biophys. Acta 1997, 1343:203-210.10.1016/S0167-4838(97)00110-6]Search in Google Scholar
[46. Auerswald EA, Nägler DK, Gross S, Assfalg-Machleidt I, Stubbs MT, Eckerskorn C, Machleidt W, Fritz H. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B. Eur J Biochem 1996, 235(3):534-4210.1111/j.1432-1033.1996.00534.x]Search in Google Scholar
[47. Salvesen G, Parkes C, Abrahamson M, Grubb A, Barrett AJ:. Human low Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem J 1986, 234:429-434.10.1042/bj2340429]Search in Google Scholar
[48. Sueyoshi T, Hara A, Shimada T, Kimura M, Mortia T, Kato H, Iwanaga S: Molecular interaction of bovine kininogen and its derivatives with papain. J Biochem 1988, 104:200-206.10.1093/oxfordjournals.jbchem.a122442]Search in Google Scholar
[49. Turk B, Stoka V, Turk V, Johansson G, Cazzulo JJ, Bjork I: High-molecular weight kininogen binds two molecules of cysteine proteinases with different rate constants. FEBS Lett 1996, 391:109-112.10.1016/0014-5793(96)00611-4]Search in Google Scholar
[50. Bjork I, Pol E, Raub-Segall E, Abrahamson M, Rowan DA, Mort JS: Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes. Biochem J 1994, 299:219-225.10.1042/bj2990219]Search in Google Scholar
[51. Illy C, Quraishi O, Wang J, Purisima E, Vernet T, Mort JS: Role of the occluding loop in cathepsin activity. J Biol Chem 1997, 272:1197-1202.10.1074/jbc.272.2.1197]Search in Google Scholar
[52. Baudys M, Meloun B, Gan-Erdene T, Fusek M, Mares M, Kostka V, Pohl J, Blake CCF: S-S bridges of cathepsin B and H from bovine spleen: A basis for cathepsin B model building and resulting possible functional implications for determination between exo- and endopeptiase activities among cathepsins B, H, and L. Biomed. Biochim Acta 1991, 50:569-577.]Search in Google Scholar
[53. Blankenvoorde MFJ, Brand HS, Henskens YMC, Veerman ECI, Nieuw Amerongen AV: Protease inhibitors in health and disease control - Medical and industrial aspects. In: Recombinant protease inhibitors in plants. Georgetown, Texas, USA: Landes Biosci 2000, 203-214.]Search in Google Scholar
[54. Calkins CC, Sloane BF: Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995, 376(2):71-80.]Search in Google Scholar
[55. Fossum, K, Whitaker JR: Ficin and papain inhibitor from chicken egg white. Arch Biochem Biophys 1968, 125:367-375.10.1016/0003-9861(68)90672-3]Search in Google Scholar
[56. Breznik B, Mitrović A, T Lah T, Kos J: Cystatins in cancer progression: More than just cathepsin inhibitors. Biochimie 2019, 166:233–250.10.1016/j.biochi.2019.05.002]Search in Google Scholar
[57. Rawling ND, Barrett AJ: Evolution of proteins of the cystatin superfamily. Biochem Biophys Res Commun 1990, 118:103-109.]Search in Google Scholar
[58. Bezin J, Popovie T, Turk V, Brochart U, Machleidt W: Human cystatin a new protein inhibitor of cysteine proteinases. Biochem Biophys Res Commun 1984, 118:103-109.10.1016/0006-291X(84)91073-8]Search in Google Scholar
[59. Freije JP, Abrahamson M, Olafsson I, Velasco G, Grubb A, Lopez-Otin C: Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. J Biol Chem 1991, 266:20538-20543.10.1016/S0021-9258(18)54958-9]Search in Google Scholar
[60. Werle B, Sauckel K, Nathanson CM, Bjarnadottir M, Spiess E, Ebert W, Abrahamson M: Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem 2003, 384(2): 281-287.10.1515/BC.2003.031]Search in Google Scholar
[61. Sotiropoulou G, Anisowicz A, Sager R: Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J. Biol Chem 1997, 272:903-910.10.1074/jbc.272.2.903]Search in Google Scholar
[62. Cheng T, Hitomi K, van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL: Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. J Biol Chem 2006, 281(23):15893–15899.10.1074/jbc.M600694200]Search in Google Scholar
[63. Prunk M, Perišić Nanut M, Sabotič J, Kos J. Cystatins, cysteine peptidase inhibitors, as regulators of immune cell cytotoxicity. Period Biol 2016, 118(4):353-362.10.18054/pb.v118i4.4504]Search in Google Scholar
[64. Gerhartz B, Engh RA, Menttele R, Eckerskom C, Torquato R, Wittmann J, Kolb HJ, Macheidt W, Fritz H, Auerswald EA: Quail cystatin: Isolation and charactrization of a new member of the cystatin family and its hypothetical interaction with cathepsin B. FEBS Lett 1997, 412:551-558.10.1016/S0014-5793(97)00806-5]Search in Google Scholar
[65. Mashita M., Konagaya S: Cysteine proteinase inhibitor in egg of Chum salmon. J Biochem 1991, 110(5):762-766.10.1093/oxfordjournals.jbchem.a123655]Search in Google Scholar
[66. Warwas M, Gburek J, Osada J, Garab K: Purification and characterization of cystatin from duck egg white. Acta Biochim Pol 1995, 42:351–356.10.18388/abp.1995_4633]Search in Google Scholar
[67. Naknukool S, Hayakawa S, Sun Y, Ogawa M: Structural and physicochemical characteristics of novel basic proteins isolated from duck egg white. Biosci Biotech Bioch 2008, 72(8):2082–2091.10.1271/bbb.80178]Search in Google Scholar
[68. Abrahamson M, Barrett AJ, Salvesen G, Grubb A: Isolation of six cysteine proteinase inhibitors from human urine. J Biol Chem 1986, 261:11282-1128910.1016/S0021-9258(18)67380-6]Search in Google Scholar
[69. Trziszka T, Saleh Y, Kopeć W, Siewiński M, Wesierska E: Effect of hen’s age on the level of cystatin in chicken egg white. Int J Poul Sci 2004, 3:1-8.]Search in Google Scholar
[70. Calkins CC, Sloane BF: Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995, 376(2):71-80.]Search in Google Scholar
[71. Høyer-Hansen G, Blasi F, Sloane B.F: Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D., (eds) The Cancer Degradome 2008, Springer, New York.]Search in Google Scholar
[72. Leto G, Crescimanno M Flandina C: On the role of cystatin C in cancer progression. Life Sci 2018, 202:152–160.10.1016/j.lfs.2018.04.01329654808]Search in Google Scholar
[73. Nakabayashi H, Hara M, Shimuzu K: Clinicopathologic significance of cystatin C expression in gliomas. Hum Pathol 2005, 36(9):1008-1015.10.1016/j.humpath.2005.06.02116153465]Search in Google Scholar
[74. Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A, Suzumori K: The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol Oncol 2004, 92(3):881-886.10.1016/j.ygyno.2003.11.01714984956]Search in Google Scholar
[75. Strojan P, Aničin A, Svetic B, Šmid L, Kos J:. Proteolytic profile of cysteine proteases and inhibitors determines tumor cell phenotype in squamous cell carcinoma of the head and neck. Int. J Biol Markers 2011, 26(4):247–254.10.5301/JBM.2011.883322139645]Search in Google Scholar
[76. Ferguson TW, Komenda P, Tangri N: Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens 2015, 24(3):295–300.10.1097/MNH.000000000000011526066476]Search in Google Scholar
[77. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP: Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995, 47(1):312-318.10.1038/ki.1995.407731163]Search in Google Scholar
[78. Kim J, Lee CM, Kim HJ: Biomarkers for chronic kidney disease in dogs: a comparison study. J Vet Med Sci 2020, 82(8):1130-1137.10.1292/jvms.20-0125746805332581150]Search in Google Scholar
[79. Ghys L, Paepe D, Smets P, Lefebvre H, Delanghe J, Daminet S: Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med 2014, 28(4):1152-1164.10.1111/jvim.12366485794824814357]Search in Google Scholar
[80. Kovarikova S: Indirect markers of glomerular filtration rate in dogs and cats: a review. Vet Med 2018, 63:395-412.10.17221/77/2017-VETMED]Search in Google Scholar
[81. Miyagawa Y, Takemura N, Hirose H: Evaluation of the measurement of serum cystatin C by an enzyme-linked immunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci 2009, 71:1169–1176.10.1292/jvms.71.116919801896]Search in Google Scholar
[82. Antognoni MT, Siepi D, Porciello F, Rueca F, Fruganti G: Serum cystatin-C evaluation in dogs affected by different diseases associated or not with renal insufficiency. Vet Res Commun 2007, 31(Suppl 1):269–271.10.1007/s11259-007-0044-117682892]Search in Google Scholar
[83. Martin C, Péchereau D, De la Farge F, Braun JP: Cystatine C plasmatique chez le chat: Les technique actuelles ne permettent pas de l’utiliser comme marqueur d’insufficance rénale. Rev Med Vet 2002, 153:305–310.]Search in Google Scholar
[84. Poswiatowska-Kaszczyszyn I. Usefulness of serum cystatin C measurement for assessing renal function in cats. Bull Vet Inst Pulawy 2012, 56:235–239.10.2478/v10213-012-0042-0]Search in Google Scholar
[85. Ghys LF, Paepe D, Lefebvre HP, Reynolds BS, Croubels S, Meyer E, Delanghe JR, Daminet S: Evaluation of cystatin C for the detection of chronic kidney disease in cats. J Vet Intern Med 2016, 30(4):1074-82.10.1111/jvim.14256510842227461722]Search in Google Scholar
[86. Ghys LFE, Paepe D, Taffin ERL, Vandermeulen E, Duchateau L, Smets PMY, Delanghe J, Daminet S: Serum and urinary cystatin C in cats with feline immunodeficiency virus infection and cats with hyperthyroidism. J Feline Med Surg 2016, 18(8):658-65.10.1177/1098612X1559234326101237]Search in Google Scholar
[87. Tizon B, Ribe EM, Mi W, Troy CM, Levy E: Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J Alzheimers Dis 2010, 19:885–894.10.3233/JAD-2010-1291288917520157244]Search in Google Scholar
[88. Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E: Cystatin C inhibits amyloid-beta deposition in Alzheimer’s disease mouse models. Nat Genet 2007, 39(12):1440-1442.10.1038/ng.2007.2918026100]Search in Google Scholar
[89. Gauthier S, Kaur G, Mi W, Tizon B, Levy E: Protective mechanisms by cystatin C in neurodegenerative diseases. Front Biosci 2011, 3:541–554.10.2741/s170303862521196395]Search in Google Scholar
[90. Stańczykiewicz B, Jak ubik-Witkowska M, Rutkowska M, Polan owski A, Gbur ek J, Gołąb K, Juszczyńs ka K, Trzis zka T, Rymaszews ka J : Beneficial effect of ovocystatin on the cognitive decline in APP/PS1 transgenic mice. Adv Med Sci 2019, 64(1):65-71.10.1016/j.advms.2018.08.00230504006]Search in Google Scholar
[91. Schelp FP, Pongpaew P: Protection against cancer through nutritionally-induced increase of endogenous proteinase inhibitors - a hypothesis. Int J Epidemiol 1988, 17(2):287-92.10.1093/ije/17.2.2872456996]Search in Google Scholar
[92. Bjornland K, Buo L, Kjonniksen I, Larsen M, Fodstad O, Johansen HT, Aasen AO: Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro. Anticancer Res 1996, 16(4A):1627-1631.]Search in Google Scholar
[93. Ervin H, Cox JL: Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression. Cancer Cell Int 2005, 5(1):14.10.1186/1475-2867-5-14115691815904519]Search in Google Scholar
[94. Xie Q, Tang N, Lin Y, Wang X, Lin X, Lin J: Recombinant adenovirus snake venom cystatin inhibits the growth, invasion, and metastasis of B16F10 cells in vitro and in vivo. Melanoma Res 2013, 23(6):444-51.10.1097/CMR.0000000000000031]Search in Google Scholar
[95. Ren WP, Sloane BF: Cathepsins D and B in breast cancer. Cancer Treat Res 1996, 83:325-52.10.1007/978-1-4613-1259-8_16]Search in Google Scholar
[96. Laurent-Matha V, Huesgen PF, Masson O, Derocq D, Prébois C, Gary-Bobo M, Lecaille F, Rebière B, Meurice G, Oréar C, Hollingsworth RE, Abrahamson M, Lalmanach G, Overall CM, Liaudet-Coopman E: Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J 2012, 26(12):5172-81.10.1096/fj.12-205229]Search in Google Scholar
[97. Lenarcic B, Kos J, Dolenc I, Lucovnik P, Krizaj I, Turk V. Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. Biochem Biophys Res Commun 1988, 154(2):765-72.10.1016/0006-291X(88)90206-9]Search in Google Scholar
[98. Tokyol C, Köken T, Demirbas M, Dilek FH, Yörükoglu K, Mungan U, Kirkali Z: Expression of cathepsin D in bladder carcinoma: correlation with pathological features and serum cystatin C levels. Tumori 2006, 92(3):230–235.10.1177/030089160609200308]Search in Google Scholar
[99. Aghdassi AA, John DS, Sendler M, Weiss FU, Reinheckel T, Mayerle J, Lerch MM: Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis. J Biol Chem 2018, 293(3):1018–1029.10.1074/jbc.M117.814772577724429229780]Search in Google Scholar
[100. Berquin IM, Sloane BF: Cathepsin B expression in human tumors. Adv Exp Med Biol 1996, 389:281-29410.1007/978-1-4613-0335-0_358861022]Search in Google Scholar
[101. Lie MA, Loos BG, Henskens YM, Timmerman MF, Veerman EC, van der Velden U, van der Weijden GA. Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokers. J Clin Periodontol 2001, 28(10):979-98410.1034/j.1600-051x.2001.028010979.x11686817]Search in Google Scholar
[102. Buttle DJ, Bramwell H, Hollander AP: Proteolytic mechanisms of cartilage breakdown: A target for arthritis therapy? J Clin Pathol 1995, 48:167-177.10.1136/mp.48.4.M16740795616696000]Search in Google Scholar
[103. Požgan U, Caglič D, Rozman B, Nagase H, Turk V, Turk B: Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis, Biological Chemistry 2010, 391(5):571-579.10.1515/bc.2010.035]Search in Google Scholar
[104. Kobayashi H, Ohi H, Sugimura M, Shinohara H, Fujii T, Terao T: Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res 1992, 52:3610-3614.]Search in Google Scholar
[105. Levicar N, Kos J, Blejec A, Golouh R, Vrhovec I, Frkovic-Grazio S, Lah TT: Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Epidemiol 2002, 26(1):42–49.10.1016/S0361-090X(02)00015-6]Search in Google Scholar
[106. Schmalfeldt B, Kuhn W, Reuning U, Pache L, Dettmar P, Schmitt M, Janicke F, Hofler H, Graeff H: Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, and inhibitors types 1 and 2. Cancer Res 1995, 55:3958-3963.]Search in Google Scholar
[107. Keppler D, Abrahamson M, Sordat B: Secretion of cathepsin B and tumour invasion. Biochem Soc Trans 1994, 22:43-49.10.1042/bst0220043]Search in Google Scholar
[108. Kobayashi H, Sugino D, She MY, Ohi H, Hirashima Y, Shinohara H, Fujie M, Shibata K, Terao T: A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis. Eur J Biochem 1998, 1;253(3):817-826.10.1046/j.1432-1327.1998.2530817.x]Search in Google Scholar
[109. Thomssen C, Oppelt P, Janicke F, Ulm K, Harheck N, Hofler H, Kuhn W, Graeff H, Schmitt M: Identification of low-risk node-negative breast cancer patients by tumors biological factors PAI-I and cathepsin L. Anticancer Res 1998. 18, 2173 - 2180.]Search in Google Scholar
[110. Saleh Y, Siewinski M, Kielan W, Ziolkowski P: Activities of cysteine proteinases cathepsin B, L and their inhibitors: regulation of cathepsin B and L expression by egg white cysteine proteinase inhibitor. J Exp Ther Oncol 2003, 3:319–324.10.1111/j.1533-869X.2003.01105.x]Search in Google Scholar
[111. Verdot L, Lalmanach G, Vercruysse V, Hartmann S, Lucius R, Hoebeke J, Gauthier F, Vray B: Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J Biol Chem 1996, 271(45):28077-28081.10.1074/jbc.271.45.28077]Search in Google Scholar
[112. Das L, Datta N, Bandyopadhyay S, Das PK: Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol 2001, 166(6):4020-4028.10.4049/jimmunol.166.6.4020]Search in Google Scholar
[113. Henskens YM, Veerman EC, Nieuw Amerongen AV.. Cystatins in health and disease. Biol Chem Hoppe Seyler 1996, 377(2):71-8610.1515/bchm3.1996.377.2.71]Search in Google Scholar
[114. Aoki H, Akaike T, Abe K, Kuroda M, Arai S, Okamura R Neji A, Maeda H: Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo. Antimicrob Agent Chemother 1995, 39:846-849.10.1128/AAC.39.4.846]Search in Google Scholar
[115. Kondo H, Ijiri S, Abe K, Maeda H, Arai S: Inhibitory effect of oryzacystatins and a truncation mutant of the replication of poliovirus in infected Vero cells. FEBS Lett 1992, 299:48-50.10.1016/0014-5793(92)80097-Z]Search in Google Scholar
[116. Kan Y, Okabayashi T, Yokota S, Yamamoto S, Fujii N, Yamashita T: Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway. J Virol 2012, 86(19):10338–10346.10.1128/JVI.01196-12]Search in Google Scholar
[117. Blankenvoorde MFJ, Henskens YMC, Van’t Hof W: Antibacterial activity against Porphyromonas gingivalis by cystatins. In: Hopsu Havu VK, Jarvinen M, Kirschke H, eds. Proteolysis in cell fuctions. Amsterdam: IOS Press. 1997, 532-539.]Search in Google Scholar
[118. Naito Y, Sasaki M, Umemoto T: Bacterial effect of rat cystatin S on an oral bacterium, Porphyromonas gingivalis. Comp Biochem Physiol 1995, 110:71-75.10.1016/0742-8413(94)00070-Q]Search in Google Scholar
[119. Grenier D: Effect of protease inhibitors on in vitro growth of Porphyromonas gingivalis. Microb Ecol Health Dis 1992, 5:133-138.10.3109/08910609209141307]Search in Google Scholar
[120. Takahashi M, Tezuka T, Katunuma N: Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin A in skin cornified envelope. FEBS Lett 1994, 355:275-278.10.1016/0014-5793(94)01196-6]Search in Google Scholar
[121. Melo P, El Chamy Maluf S, Azevedo MF, Paschoalin T, Budu A, Bagnaresi P, Henrique-Silva F, Soares-Costa A, Gazarini ML, Carmona AK: Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4. Parasitol Int 2018, 67(2):233–236.10.1016/j.parint.2017.12.00529288140]Search in Google Scholar
[122. Kolaczkowska A, Kolaczkowski M, Sokolowska A, Miecznikowska H, Kubiak A, Rolka K, Polanowski A: The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance. Mycoses 2010, 53(4):314–320.10.1111/j.1439-0507.2009.01722.x19549107]Search in Google Scholar
[123. Luaces AL, Barrett AJ: Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica. Biochem J 1998, 250(3):903-909.10.1042/bj250090311489412898937]Search in Google Scholar
[124. Wesierska, E, Saleh, Y, Trziszka, T, Kopeć W, Siewiński M, Korzekwa K. Antimicrobial activity of chicken egg white cystatin. World J Microbiol Biotechnol 2005, 21:59–64.10.1007/s11274-004-1932-y]Search in Google Scholar
[125. Benjakul S, Visessanguan W, An H:. Properties of cysteine proteinase inhibitors from black gram and rice bean. J Food Chem 2001, 25:211-227.10.1111/j.1745-4514.2001.tb00735.x]Search in Google Scholar
[126. Izquierdo-Pulido ML, Haard TA, Hung J, Haard NF: Oryzacystatin and other proteinase inhibitors in rice grain: potential use as a fish processing aid. J Agric Food Chem 1994, 42:616-622.10.1021/jf00039a003]Search in Google Scholar
[127. Singh A, Benjakul S: Proteolysis and Its Control Using Protease Inhibitors in Fish and Fish Products: A Review. Compr. Rev. Food Sci. Food Saf 2018, 17:496-509.10.1111/1541-4337.1233733350077]Search in Google Scholar
[128. Tzeng SS, Chen GH, Chung YC, Jiang ST: Expression of soluble form carp (Cyprinus carpio) ovarian cystatin in Escherichia coli and its purification. J Agric Food Chem 2001, 49:4224-4230.10.1021/jf010513511559115]Search in Google Scholar
[129. Jiang ST, Tzeng SS, Wu WT, Chen GH: Enhanced expression of chicken cystatin as a thioredoxin fusion form in Escherichia coli AD494(DE3)pLysS and its effect on the prevention of surimi gel softening. J Agric food Chem 2002, 50:3731-3737.10.1021/jf020053v12059151]Search in Google Scholar
[130. Jiang ST, Hsieh JF, Tsai GJ: Interactive effects of microbial transglutaminase and recombinant cystatin on the mackerel and hairtail muscle protein. J Agric Food Chem 2004, 52(11):3617–3625.10.1021/jf035102y15161240]Search in Google Scholar
[131. Chen GH, Tang SJ, Chen CS, Jiang ST: High-level production of recombinant chicken cystatin by Pichiapastoris and its application in mackerel surimi. J Agric Food Chem 2001, 49(2):641–646.10.1021/jf000992s11262005]Search in Google Scholar
[132. Szpak M, Trziszka T, Polanowski A, Gburek J, Gołąb K, Juszczyńska K, Janik P, Malicki A, Szyplik K: Evaluation of the antibacterial activity of cystatin against selected strains of Escherichia coli. Folia Biologica (Kraków), 2014, 62:187-192.10.3409/fb62_3.18725403072]Search in Google Scholar